Market Overview:
The global Shigella nucleic acid test kit market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of shigellosis, rising demand for rapid and accurate diagnosis, and technological advancements in nucleic acid testing (NAT) technology. The global Shigella nucleic acid test kit market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dry PCR and fluorescence PCR. The fluorescence PCR segment is expected to grow at a higher CAGR than the dry PCR segment during the forecast period owing to its advantages such as high sensitivity and specificity, short turnaround time, low cost per assay point compared with other methods such as culture-based assays or enzyme-linked immunosorbent assay (ELISA), and easy automation potential. On the basis of application, hospitals are expected to account for a larger share of this market than clinics duringthe forecast period owingto their greater need for rapid diagnosisof infectious diseasesand growing demandfor advanced diagnostic tests.
Product Definition:
A Shigella nucleic acid test kit is a diagnostic tool used to detect the presence of Shigella bacteria in a sample. The kit uses polymerase chain reaction (PCR) technology to amplify and detect specific DNA sequences from the Shigella bacteria. This allows for rapid and accurate detection of the bacteria, which can help to guide treatment decisions.
Dry PCR:
Dry PCR, also known as DNA-based PCR (Nucleic Acid Based Test) is a new and innovative technology that uses dry reagents to detect Shigella bacteria in the sample. The advantages of this technique are that it does not require any special equipment or chemicals other than what is provided with the kit itself. It also helps save time and costs by eliminating labor costs associated with traditional wet methods of testing.
Fluorescence PCR:
Fluorescence Polymerase Chain Reaction (PCR) is a technique that involves the use of fluorescent dyes to amplify specific DNA or RNA sequences. The test uses an automated instrument to detect and measure fluorescence from a sample that is then amplified in real-time through the PCR process.
The technology has several advantages such as it can be used for both positive.
Application Insights:
The global shigella nucleic acid test kit market is segmented based on application as hospital, clinic and others. The hospital application segment dominated the overall market in terms of revenue in 2017 owing to a rising number of shigellosis cases across the world. In addition, an increase in healthcare spending along with growing awareness about preventive measures taken against Shigella is expected to drive demand for SNGAC over the forecast period.
The other applications include pre-enrolment testing and home testing kits. Pre-enrolment tests are used before a patient visits a doctor or goes for checkups at clinics or hospitals due to symptoms such as diarrhea that last for more than 3 days together with one of the following signs: feverishness, nausea and abdominal pain/cramps (or gas).
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-developed healthcare infrastructure and government initiatives to promote vaccination programs are some factors responsible for its large share. In addition, the rising incidence of shigellosis in this region is anticipated to drive demand for diagnostic tests over the forecast period. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing R&D investments by global players and rising awareness about shigella testing among people living in rural as well as urban areas. Moreover, improving healthcare infrastructure and growing penetration of insurance coverage are also likely contributors toward regional growth over the next eight years (2018– 2030).
Growth Factors:
- Increasing incidence of shigellosis: The global incidence of shigellosis is increasing due to the growing population and their changing lifestyles. This is leading to an increase in the demand for Shigella nucleic acid test kits.
- Growing awareness about shigellosis: There is a growing awareness among people about the symptoms and risks associated with shigellosis. This is driving the demand for Shigella nucleic acid test kits as they can help in early diagnosis and treatment of the disease.
- Technological advancements: The development of new technologies has led to the introduction of novel Shigella nucleic acid test kits that are more accurate and sensitive than traditional methods. This is contributing to the growth of this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Shigella Nucleic Acid Test Kit Market Research Report
By Type
Dry PCR, Fluorescence PCR
By Application
Hospital, Clinic
By Companies
Geneodx, Mole, Bioperfectus, BioGerm, Kinghawk, BGI, HFBiotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Shigella Nucleic Acid Test Kit Market Report Segments:
The global Shigella Nucleic Acid Test Kit market is segmented on the basis of:
Types
Dry PCR, Fluorescence PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Geneodx
- Mole
- Bioperfectus
- BioGerm
- Kinghawk
- BGI
- HFBiotech
Highlights of The Shigella Nucleic Acid Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry PCR
- Fluorescence PCR
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Shigella Nucleic Acid Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Shigella Nucleic Acid Test Kit is a laboratory tool used to detect the presence of Shigella bacteria in samples.
Some of the key players operating in the shigella nucleic acid test kit market are Geneodx, Mole, Bioperfectus, BioGerm, Kinghawk, BGI, HFBiotech.
The shigella nucleic acid test kit market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Shigella Nucleic Acid Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Shigella Nucleic Acid Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Shigella Nucleic Acid Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Shigella Nucleic Acid Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Shigella Nucleic Acid Test Kit Market Size & Forecast, 2020-2028
4.5.1 Shigella Nucleic Acid Test Kit Market Size and Y-o-Y Growth
4.5.2 Shigella Nucleic Acid Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry PCR
5.2.2 Fluorescence PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Shigella Nucleic Acid Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Shigella Nucleic Acid Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry PCR
9.6.2 Fluorescence PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry PCR
10.6.2 Fluorescence PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry PCR
11.6.2 Fluorescence PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry PCR
12.6.2 Fluorescence PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry PCR
13.6.2 Fluorescence PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Shigella Nucleic Acid Test Kit Market: Competitive Dashboard
14.2 Global Shigella Nucleic Acid Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Geneodx
14.3.2 Mole
14.3.3 Bioperfectus
14.3.4 BioGerm
14.3.5 Kinghawk
14.3.6 BGI
14.3.7 HFBiotech
